Catalyst Wire Dossier Catalyst Wire Dossier

belagenpumatucel-L

belagenpumatucel-L · EMD Serono
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for belagenpumatucel-L, covering 2015-11-20 to 2015-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START) [Phase 3]

See pricing